These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30970354)

  • 1. Safety of Oral and Intravenous Iron.
    DeLoughery TG
    Acta Haematol; 2019; 142(1):8-12. PubMed ID: 30970354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review.
    DeLoughery TG; Jackson CS; Ko CW; Rockey DC
    Clin Gastroenterol Hepatol; 2024 Aug; 22(8):1575-1583. PubMed ID: 38864796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of intravenous iron use in chronic kidney disease.
    Kalra PA; Bhandari S
    Curr Opin Nephrol Hypertens; 2016 Nov; 25(6):529-535. PubMed ID: 27557350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer formulations of intravenous iron: a review of their chemistry and key safety aspects - hypersensitivity, hypophosphatemia, and cardiovascular safety.
    Blumenstein I; Shanbhag S; Langguth P; Kalra PA; Zoller H; Lim W
    Expert Opin Drug Saf; 2021 Jul; 20(7):757-769. PubMed ID: 33993818
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention and management of acute reactions to intravenous iron in surgical patients.
    Gómez-Ramírez S; Shander A; Spahn DR; Auerbach M; Liumbruno GM; Vaglio S; Muñoz M
    Blood Transfus; 2019 Mar; 17(2):137-145. PubMed ID: 30418128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management.
    Rampton D; Folkersen J; Fishbane S; Hedenus M; Howaldt S; Locatelli F; Patni S; Szebeni J; Weiss G
    Haematologica; 2014 Nov; 99(11):1671-6. PubMed ID: 25420283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hypophosphataemia after intravenous iron administration.
    Anand G; Schmid C
    BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28289000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous iron: a framework for changing the management of iron deficiency.
    Auerbach M; Gafter-Gvili A; Macdougall IC
    Lancet Haematol; 2020 Apr; 7(4):e342-e350. PubMed ID: 32220343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of iron-deficiency anaemia in pregnancy and postpartum.
    Breymann C; Honegger C; Hösli I; Surbek D
    Arch Gynecol Obstet; 2017 Dec; 296(6):1229-1234. PubMed ID: 28940095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of available treatment options for iron-deficiency anemia.
    Muñoz M; Gómez-Ramírez S; Bhandari S
    Expert Opin Drug Saf; 2018 Feb; 17(2):149-159. PubMed ID: 29103332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous iron sucrose: an alternative for oral iron in pregnancy with iron deficiency anemia.
    Shi Q; Li J; Yao Q; Mi C; Yang J; Xing A
    Ann Hematol; 2015 Mar; 94(3):523-5. PubMed ID: 25123238
    [No Abstract]   [Full Text] [Related]  

  • 12. A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.
    Birgegård G; Henry D; Glaspy J; Chopra R; Thomsen LL; Auerbach M
    Pharmacotherapy; 2016 Apr; 36(4):402-14. PubMed ID: 26927900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of intravenous iron in clinical practice: implications for anemia management protocols.
    Aronoff GR
    J Am Soc Nephrol; 2004 Dec; 15 Suppl 2():S99-106. PubMed ID: 15585604
    [No Abstract]   [Full Text] [Related]  

  • 14. Expert consensus guidelines: Intravenous iron uses, formulations, administration, and management of reactions.
    Van Doren L; Steinheiser M; Boykin K; Taylor KJ; Menendez M; Auerbach M
    Am J Hematol; 2024 Jul; 99(7):1338-1348. PubMed ID: 38282557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of intravenous iron preparations: systematic review and meta-analysis.
    Avni T; Bieber A; Grossman A; Green H; Leibovici L; Gafter-Gvili A
    Mayo Clin Proc; 2015 Jan; 90(1):12-23. PubMed ID: 25572192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of iron deficiency anemia: practical considerations.
    Taylor S; Rampton D
    Pol Arch Med Wewn; 2015; 125(6):452-60. PubMed ID: 25922941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Iron replacement. Oral or parenteral?].
    Gattermann N
    Internist (Berl); 1998 May; 39(5):532-3. PubMed ID: 9647996
    [No Abstract]   [Full Text] [Related]  

  • 18. Parenteral iron supplementation for the treatment of iron deficiency anemia in children.
    Surico G; Muggeo P; Muggeo V; Lucarelli A; Martucci T; Daniele M; Rigillo N
    Ann Hematol; 2002 Mar; 81(3):154-7. PubMed ID: 11904741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous iron: an update.
    Lucas S; Garg M
    Intern Med J; 2024 Jan; 54(1):26-34. PubMed ID: 37490496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-intravenous approaches to iron therapy in chronic kidney disease: will it improve the benefit-to-risk ratio?
    Besarab A
    Nephrol News Issues; 2014 Feb; 28(2):12, 14-5. PubMed ID: 24649747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.